We found that a significant increase in the dose of Ang II to 3 mg/kg/day in BMT ApoE−/− mice was required to increase aneurysm formation and atherosclerosis to the level observed in non-BMT ApoE−/− mice treated with 0.8 mg/kg/day Ang II. The gene discussed is APOE; the disease is atherosclerosis.